Answer
The safety and efficacy of Nexplanon (etonogestrel) have been established in women between 18 and 40 years of age.
Sources for this answer
- Nexplanon 68 mg implant for subdermal useOrganon Pharma (UK) Limited · emc · SmPC §4.1 Therapeutic Indications · Version 24Document updated
Sources checked